Evaluate the Pharmacokinetics and Safety of MK-4448 in Participants With Nonvalvular Atrial Fibrillation (Study MK-4448-006)
This study has been completed.
Sponsor:
Merck
Collaborator:
Portola Pharmaceuticals
Information provided by:
Merck
ClinicalTrials.gov Identifier:
NCT01229254
First received: September 9, 2010
Last updated: June 22, 2011
Last verified: June 2011
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | April 2011 |
| Primary Completion Date: | December 2010 (Final data collection date for primary outcome measure) |